Audible. Prime Member exclusive offer. First 3 months free, $14.95 a month after 3 months. Cancel anytime. Offer ends July 31, 2024, 11:59 PM PT. Get this deal

NEJM This Week — July 11, 2024
Jul 10 2024
Length: 36 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

NEJM This Week — July 11, 2024

Listen for free

View show details

Summary
Featuring articles on semaglutide and chronic kidney disease in type 2 diabetes, felzartamab in kidney-transplant rejection, bulevirtide and peginterferon for chronic hepatitis D, and nirsevimab and hospitalization for RSV bronchiolitis; a review article on malnutrition in adults; a case report of an infant with vomiting and hypercalcemia; and Perspectives on Medicare Advantage and consolidation’s new frontier, on orphan drugs and priorities for the future, on funding post-authorization vaccine-safety science, and on standing on her own two feet.

Show more Show less

Physical Illness & Disease Hygiene & Healthy Living

Show more Show less

What listeners say about NEJM This Week — July 11, 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon